First Time Loading...
T

Toho Chemical Industry Co Ltd
TSE:4409

Watchlist Manager
Toho Chemical Industry Co Ltd
TSE:4409
Watchlist
Price: 506 JPY -0.59% Market Closed
Updated: May 12, 2024
Financials Section:
Income Statement Balance Sheet Cash Flow Statement

Balance Sheet

69.4B
+2%
Assets
Growth Rates:
1 Year
+0%
3 Years
+23%
5 Years
+34%
7 Years
+50%
10 Years
+54%
50.7B
+2%
Liabilities
Growth Rates:
1 Year
-2%
3 Years
+20%
5 Years
+27%
7 Years
+38%
10 Years
+44%
18.7B
+2%
Equity
Growth Rates:
1 Year
+6%
3 Years
+31%
5 Years
+54%
7 Years
+97%
10 Years
+92%

Balance Sheet Decomposition
Toho Chemical Industry Co Ltd

69.4B
Assets
50.7B
Liabilities
69.4B
Assets
50.7B
Liabilities
Current Assets 38.4B
Cash & Short-Term Investments 7.1B
Receivables 13.8B
Other Current Assets 17.5B
Non-Current Assets 31B
PP&E 24.1B
Intangibles 1.2B
Other Non-Current Assets 5.7B
Current Liabilities 25.8B
Accounts Payable 9.8B
Accrued Liabilities 256m
Other Current Liabilities 15.8B
Non-Current Liabilities 24.9B
Long-Term Debt 17.5B
Other Non-Current Liabilities 7.4B

Balance Sheet
Toho Chemical Industry Co Ltd

Rotate your device to view
Balance Sheet
Currency: JPY
Mar-2014 Mar-2015 Mar-2016 Mar-2017 Mar-2018 Mar-2019 Mar-2020 Mar-2021 Mar-2022 Mar-2023
Assets
Cash & Cash Equivalents
4 093
4 629
5 439
7 026
8 985
8 264
9 001
9 285
7 502
6 078
Cash Equivalents
4 093
4 629
5 439
7 026
8 985
8 264
9 001
9 285
7 502
6 078
Total Receivables
9 273
8 972
8 876
9 319
10 319
11 373
9 992
10 913
13 314
13 968
Accounts Receivables
9 273
8 972
8 876
9 319
10 319
11 373
9 992
10 913
11 923
12 610
Other Receivables
0
0
0
0
0
0
0
0
1 391
1 358
Inventory
8 718
8 908
8 745
8 738
9 794
9 964
9 980
9 775
12 595
16 070
Other Current Assets
896
953
974
1 332
778
1 006
570
953
1 491
852
Total Current Assets
22 980
23 462
24 034
26 415
29 876
30 607
29 543
30 926
34 902
36 968
PP&E Net
18 259
18 036
16 933
15 447
14 489
16 211
18 364
21 283
24 703
24 220
Intangible Assets
931
1 011
931
838
828
843
1 119
1 172
1 324
1 233
Long-Term Investments
1 911
2 383
2 092
2 409
2 932
2 923
2 464
3 577
4 152
3 891
Other Long-Term Assets
1 169
1 028
1 493
1 578
1 689
1 823
1 808
1 458
1 408
1 639
Total Assets
45 250
N/A
45 920
+1%
45 483
-1%
46 687
+3%
49 814
+7%
52 407
+5%
53 298
+2%
58 416
+10%
66 489
+14%
67 951
+2%
Liabilities
Accounts Payable
7 589
7 187
6 692
7 096
8 713
8 985
7 326
7 517
9 109
9 965
Accrued Liabilities
335
346
384
381
465
494
521
539
571
579
Short-Term Debt
2 494
2 954
0
0
3 972
3 069
2 750
2 996
3 809
5 249
Current Portion of Long-Term Debt
4 746
5 714
7 834
10 266
4 749
4 171
5 952
4 800
6 501
6 435
Other Current Liabilities
1 879
2 192
2 216
2 537
3 195
3 541
2 962
4 736
5 595
3 354
Total Current Liabilities
17 043
18 393
17 126
20 280
21 094
20 260
19 511
20 588
25 585
25 582
Long-Term Debt
14 433
12 833
13 476
10 707
11 498
13 444
14 376
16 790
17 870
18 258
Deferred Income Tax
151
156
136
112
101
83
70
60
57
35
Minority Interest
76
87
86
78
77
74
71
77
91
77
Other Liabilities
3 375
3 668
4 763
5 328
5 508
5 531
5 761
5 857
6 070
6 311
Total Liabilities
35 078
N/A
35 137
+0%
35 587
+1%
36 505
+3%
38 278
+5%
39 392
+3%
39 789
+1%
43 372
+9%
49 673
+15%
50 263
+1%
Equity
Common Stock
1 755
1 755
1 755
1 755
1 755
1 755
1 755
1 755
1 755
1 755
Retained Earnings
6 259
6 037
5 678
5 868
6 738
8 432
9 555
10 240
11 314
11 971
Additional Paid In Capital
896
896
896
896
896
896
896
896
896
896
Unrealized Security Profit/Loss
488
828
0
972
1 317
1 307
875
1 653
2 034
1 870
Treasury Stock
3
4
0
4
6
6
6
6
6
163
Other Equity
777
1 271
827
695
836
631
434
506
823
1 359
Total Equity
10 172
N/A
10 783
+6%
9 896
-8%
10 182
+3%
11 536
+13%
13 015
+13%
13 509
+4%
15 044
+11%
16 816
+12%
17 688
+5%
Total Liabilities & Equity
45 250
N/A
45 920
+1%
45 483
-1%
46 687
+3%
49 814
+7%
52 407
+5%
53 298
+2%
58 416
+10%
66 489
+14%
67 951
+2%
Shares Outstanding
Common Shares Outstanding
21
21
21
21
21
21
21
21
21
21

See Also

Summary
Intrinsic value, competitors valuation, and company profile.
DCF Valuation
Stock valuation using Discount Cash Flow valuation method.
Relative Valuation
Stock valuation using valuation multiples.
Wall Street Estimates
Price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
Stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
ALPHA SPREAD
Join more than 136,500+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.